Table 3 Number of intragenic CNVs and samples for each array design.

From: Exon-focused targeted oligonucleotide microarray design increases detection of clinically relevant variants across multiple NHS genomic centres

Arrays

# of intragenic CNVs

# samples

% of total samples

Intragenic CNVs/sample

CytoSure v2 8 × 60 K

8,560

16,830

50

0.5

CytoSure v3 8 × 60 K

7,930

10,926

73

0.73

Back to article page